Feasibility of a Diet Intervention for Juvenile Arthritis
- Sponsor
- The Hospital for Sick Children
- Study ID
- NCT06474546
- Status
- Recruiting
Conditions
- Arthritis, Childhood
- Arthritis, Juvenile
- Juvenile Idiopathic Arthritis
Eligibility Criteria
- Sex
- ALL
- Age
- 8 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Diet intervention — OTHERA diet based on the principles of the Mediterranean Diet (MedDiet): consists of an abundance of plant foods - unrefined cereals, fruit, vegetables, and extra-virgin olive oil - a moderate consumption of poultry, dairy products, eggs, and low consumption of sweets and red meats. All subjects will be instructed to follow the MedDiet for 8 weeks by the study team. Families will be given the option to continue for 12 weeks if they wish to do so.
Study Details
Families of children with arthritis are highly interested in the benefits of diet to improve their child's disease and future health outcomes. Previous research shows that the germs - bacteria and other organisms - that live in the intestines (gut microbiome) are important to how well immune systems work, and that what people eat changes their gut microbiome. The investigators want to study whether a certain diet - based on the principles of the Mediterranean Diet - will improve arthritis for children and whether it was changes in the microbiome that led to improvement. Fifty-four participants in this study will change their diet for an 8-week period, and will have the option of remaining on the diet for an additional 4 weeks. At three time points during the study (beginning, 8 weeks, and 12 weeks), participants will provide stool and blood samples, will complete questionnaires about diet and other aspects of lifestyle and health, and will complete a disease assessment by a clinician. From collecting all these samples and information, the investigators will be able to determine if the diet was successful in improving disease activity in children with arthritis and if the gut microbiome was changed as well. This study will help the investigators figure out if a larger, and more definitive, study like this is possible to do in children with arthritis and will help the investigators design a bigger multinational study to confirm how diet affects disease outcomes and the microbiome in children with arthritis. If successful, this research will provide scientific knowledge to help families make their way through this difficult to- navigate topic.
Key Dates
- Start date
- Apr 7, 2025
- Status verified
- Apr 2026
- Primary completion
- Aug 31, 2028
- Completion
- Oct 31, 2028
Study Design
- Enrollment
- 54 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: InterventionDiet (MedDiet)
Primary Outcome Measure
(Feasibility 1) Participant accrual rate: [ Time Frame: 8-12 weeks ]
Central Contacts
- Hayyah Clairman416-813-7979
Related Studies
- Development of a Therapeutic Endpoint in Pediatric Rheumatologic ConditionsRecruiting · Children's National Research Institute · Washington D.C., District of Columbia
- Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.PHASE3 · Recruiting · AbbVie · Phoenix, Arizona
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsPHASE3 · Recruiting · Janssen Research & Development, LLC · Atlanta, Georgia
- Pain in Juvenile ArthritisRecruiting · Washington University School of Medicine · St Louis, Missouri